AB Science SA

09/22/2021 | Press release | Distributed by Public on 09/22/2021 10:10

AB Science receives Health Canada approval letter to commence Phase I/II trial of AB8939 in the treatment of Acute Myeloid Leukemia

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.